Comparative Efficacy and Safety of Infliximab and Vedolizumab Therapy in Patients with Inflammatory Bowel Disease: a Systematic Review and Meta-Analysis
BMC Gastroenterology(2022)
Key words
Inflammatory bowel disease,Vedolizumab,Pediatrics,Systematic review
AI Read Science
Must-Reading Tree
Example

Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined